83 results on '"K. Haustermans"'
Search Results
2. OC-0511 Urethra and bladder dose-effect relations for genitourinary toxicity after EBRT for prostate cancer
3. SP-0917 Patterns of failure in the phase III randomized controlled FLAME trial for localized prostate cancer
4. OC-0259 Focal boosting in prostate cancer: risk modelling for individualized therapy
5. PH-0328 Current practice for selection of adult patients for proton therapy across Europe
6. SP-0023 Technical developments in the radiation treatment of oesophageal cancer
7. OC-0631 Proton and photon treatment planning comparison for oesophageal cancer between six European centres
8. PD-0818 Dose prediction with deep learning: the effect of data quality and quantity in the model’s accuracy
9. PD-0881 Deep learning dose prediction as a tool to evaluate treatment complications based on NTCP models
10. PO-1437 Endocrine Late- Effects after Childhood and Adolescent Cancer - The Pan-European Registry HARMONIC
11. OC-0209: 'SBRT and the Boost', a love story: primary endpoint analysis of the phase II hypo-FLAME trial
12. PO-1200: Multimodality treatment for M1a prostate cancer: toxicity and early oncological results
13. PO-1591: Dosimetric accuracy of beam gating, MLC tracking and couch tracking to manage prostate rotation
14. PH-0114: Dose-volume effects for GI toxicity following EBRT for prostate cancer in the FLAME trial
15. OC-0612: The FLAME trial: benefit of a focal boost for prostate cancer on biochemical disease-free survival
16. OC-0315: Quality of life after EBRT with or without focal boost for prostate cancer in the FLAME trial
17. SP-0502: Organ preservation: where are we and where do we go?
18. PO-1201: Oligorecurrent prostate cancer treated with metastasis-directed therapy: oncological outcomes
19. EP-1556 The effect of an endorectal balloon on GI toxicity after EBRT for localized prostate cancer
20. PV-0622 NCTP model for postoperative pulmonary complications after trimodality therapy in esophageal cancer
21. OC-0510 MRI radiomics to predict tumour response in patients with locally advanced rectal cancer
22. OC-0160 When PI-RADS and ISUP meet each other: identification of candidates for pelvic lymph node dissection
23. OC-0380 Dose response relation in esophageal cancer after neoadjuvant therapy: multi-institutional analysis
24. PV-0100: Impact of lung dose on postoperative complications after trimodality treatment in esophageal cancer
25. EP-2308: Inhibition of lipogenesis: a promising approach to optimise the treatment of rectal cancer
26. EP-1923: Integration of microscopic spread and geometric uncertainties into a single target volume expansion
27. EP-2144: Tumor and OAR delineation variation – Dice coefficient versus dose assessed with automated planning
28. OC-0514: VMAT treatment planning for head-and-neck cancer with the novel fast-rotating linac halcyon
29. PO-0805 Analysis of esophageal cancer patients treated with neoadjuvant therapy who never made it to surgery
30. EP-1552 Impact of MRI on prostate cancer risk classification: game changer for therapeutic decision making?
31. PO-0928 Treatment plan quality assessment for focal dose escalation in prostate cancer
32. PO-0856 Metastasis-directed therapy for oligoprogressive castration refractory prostate cancer
33. OC-0056: FLAME: Influence of dose escalation to 95Gy for prostate cancer on urethra-related toxicity and QOL
34. EP-1590: Can bolus range shifting improve plan quality in the IMPT of head and neck cancer?
35. PO-0977: Plasma lipidomics for predictive biomarker analysis in rectal cancer
36. PO-0860: Characterization of a novel liquid fiducial marker for organ motion monitoring in prostate SBRT
37. OC-0499: Evaluation of prostate tumor delineations on multiparametric MRI in a multicenter radiotherapy trial
38. SP-0128: Multi-parametric functional imaging for lesion identification and RT personalisation in prostate cancer
39. OC-0162: A comparison of two neoadjuvant chemoradiotherapy regimens for esophageal cancer
40. PO-1008: Commissioning of IMRT/VMAT on the novel Varian Halcyon™
41. SP-0004: New tools to reduce toxicity in pelvic radiation
42. EP-1516: Evaluating a versatile new-generation anthropomorphic phantom for SBRT and thoracic IMRT/VMAT
43. SP-0389: Imaging and molecular profiles to predict response to chemoradiotherapy: where do we stand?
44. PD-0462: Towards dosimetric tracking with adaptive VMAT?
45. PD-0461: Characterization of nodal metastases in prostate cancer patients at high risk for lymph node involvement
46. Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: final analyses
47. PV-0121: Falcon based Clinical Target Volume Delineation to support Inter-Society Rectal Cancer Guidelines
48. OC-0282: FLAME randomised trial: 95Gy MRI-boost vs 77Gy prostate radiotherapy: toxicity and quality of life
49. OC-0164: Integrate range shifting in immobilisation for proton therapy: 3D printed materials characterisation
50. PO-0870: Fitting data of relapse-free survival after postprostatectomy RT with a comprehensive TCP model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.